Man Group’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Hold
0
939
2022
Q2
Hold
0
1726
2021
Q3
Sell
-17,237
Closed -$286K 2160
2021
Q2
$286K Sell
17,237
-22,411
-57% -$402K ﹤0.01% 1691
2021
Q1
$718K Sell
39,648
-216,941
-85% -$4.28M ﹤0.01% 1385
2020
Q4
$4.68M Buy
256,589
+32,132
+14% +$510K 0.02% 848
2020
Q3
$2.86M Buy
+224,457
New +$2.87M 0.01% 1067
2020
Q1
Sell
-15,504
Closed -$249K 1957
2019
Q4
$249K Buy
+15,504
New +$256K ﹤0.01% 1713
2019
Q3
Sell
-10,564
Closed -$210K 1954
2019
Q2
$210K Sell
10,564
-708
-6% -$13.2K ﹤0.01% 1798
2019
Q1
$190K Buy
+11,272
New +$195K ﹤0.01% 1884
2018
Q4
Sell
-67,081
Closed -$1.35M 2167
2018
Q3
$1.35M Buy
67,081
+7,402
+12% +$157K ﹤0.01% 1551
2018
Q2
$1.16M Buy
59,679
+17,622
+42% +$279K ﹤0.01% 1561
2018
Q1
$574K Buy
+42,057
New +$554K ﹤0.01% 1671

Other funds holding NXGN

Man Group's NXGN Position: Q3 2023 in Review

Man Group held its NextGen Healthcare, Inc. Common Stock (NXGN) position steady in Q3 2023 at 0 shares worth $4.1M. The position accounts for 0.01% of the portfolio, ranked #939.

Man Group first reported a position in NXGN in Q1 2018 and has held it in 10 quarters since. The position peaked at $4.68M in Q4 2020. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.

  • Man Group held 0 shares of NextGen Healthcare, Inc. Common Stock worth $4.1M as of Q3 2023.
  • Man Group left its NextGen Healthcare, Inc. Common Stock share count unchanged in Q3 2023.
  • NextGen Healthcare, Inc. Common Stock made up 0.01% of Man Group's portfolio in Q3 2023, its #939 holding.
  • Man Group first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2018 and has held it in 10 quarters since.
  • Man Group's NextGen Healthcare, Inc. Common Stock position peaked at $4.68M in Q4 2020.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.

Based on Man Group's 13F filing for Q3 2023, filed 14 Nov 2023.